Interleukin enhancer-binding factor 3 (ILF3) 抗体
Quick Overview for Interleukin enhancer-binding factor 3 (ILF3) 抗体 (ABIN7605264)
抗原
See all Interleukin enhancer-binding factor 3 (ILF3) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    
- 
                                            
原理
 - Anti-ILF3 Rabbit Monoclonal Antibody
 - 
                                            
产品特性
 - Anti-ILF3 Rabbit Monoclonal Antibody (ABIN7605264). Tested in WB, IHC, ICC/IF, IP, Flow Cytometry applications. This antibody reacts with Human, Mouse.
 - 
                                            
纯化方法
 - Affinity-chromatography
 - 
                                            
免疫原
 - A synthesized peptide derived from human ILF3
 - 
                                            
亚型
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
应用备注
 - 
                        WB 1:1000-1:5000
IHC 1:50-1:200
ICC/IF 1:50-1:200
IP 1:50
FC 1:50 - 
                                            
限制
 - 仅限研究用
 
 - 
                                            
 - 
    
- 
                                            
状态
 - Liquid
 - 
                                            
溶解方式
 - Restore with deionized water (or equivalent) for reconstitution volume of 1.0 mL
 - 
                                            
浓度
 - Lot specific
 - 
                                            
缓冲液
 - Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA.
 - 
                                            
储存液
 - Sodium azide
 - 
                                            
注意事项
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
储存条件
 - 4 °C,-20 °C
 - 
                                            
储存方法
 - Store at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles.
 
 - 
                                            
 - 
    
 -